Search

everythinglearnresearchcommunity

for

Search:↓

Transplant patients face higher skin cancer risks due to immunosuppressive therapy, requiring careful skin health monitoring.

TLR3 signaling enhances the immunosuppressive properties of human periodontal ligament stem cells.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

Scalp psoriasis is treated with topical therapies, phototherapy, and systemic medications.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Adding colchicine stopped the girl's recurring heart issues caused by lupus.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Breast implants are linked to autoimmune symptoms, with over half of patients feeling better after removal, but the exact cause is unclear and may involve bacterial biofilm.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

Antiphospholipid syndrome can severely damage adrenal glands, requiring early diagnosis and treatment.

Atypical symptoms in lupus can indicate different kidney issues.

Lupus pneumonitis can be misdiagnosed as pneumonia or tuberculosis, so consider lupus in similar cases for proper treatment.

Living with lupus as both a patient and doctor improved understanding and care for others.

Sunlight exposure improved a patient's skin condition, and there may be a link between a certain disease and skin growths; a leukemia treatment caused changes in hair color and growth.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Early diagnosis and treatment are crucial for CAPS, and Eculizumab can be effective.

Proactive physical therapy improved mobility, reduced fatigue, and pain in lupus patients.

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.

A rare autoimmune condition, Satoyoshi syndrome, can start in adults and improve with immunosuppressive treatment.

Early diagnosis, innovative treatments, and considering systemic conditions are crucial in dermatological care.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

Use the least toxic, most specific treatments for skin diseases, considering side effects and individual patient needs.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Purpura fulminans can signal underlying autoimmune disorders, not just infections.

Bullous lupus can cause severe esophageal issues but responds well to corticosteroids and azathioprine.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

More pediatric-specific research and guidelines are needed to improve hidradenitis suppurativa treatment in children and adolescents.

Higher free testosterone levels in men are linked to a stronger immune response, not weaker.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.